A study published on August 5, 2026, in *Science Translational Medicine* examined whether microorganisms obtained from healthy people could help patients with severe peanut allergies become more tolerant to peanuts. The research has also attracted attention from the scientific community because it points to a potential new role for the gut microbiome in controlling food allergies.
Researchers focused on microorganisms found in the intestines of people who do not suffer from serious food allergies. Scientists have increasingly studied the relationship between gut bacteria and the immune system, as microorganisms in the digestive tract can influence how the body's immune system responds to substances entering the body.
In the study, patients with severe peanut allergies received treatment involving microorganisms obtained from healthy donors. According to the findings, six participants subsequently showed an increased ability to tolerate peanuts.
The result is significant because people with severe food allergies currently have limited treatment options, and accidental exposure to an allergen can cause a potentially life-threatening reaction.
The researchers believe that the effect may involve changes in the way beneficial gut bacteria influence bile-acid metabolism. These biological changes could affect immune responses and potentially make the immune system less likely to react excessively to food proteins.
The study adds to growing scientific evidence that food allergies may involve more than an abnormal immune response alone. Changes or imbalances in the gut microbiome could also play a role in determining how the immune system reacts to certain foods.
However, researchers have stressed that the findings do not yet represent a cure for peanut allergy. The study involved a limited number of participants, and larger clinical trials will be required to establish the treatment's effectiveness, safety and long-term benefits.
Scientists are also exploring ways to develop more controlled microbiome-based treatments. Instead of transferring complex communities of microorganisms, future therapies could potentially use carefully selected beneficial bacteria or their biological products.
If future clinical trials confirm the findings, manipulating the gut microbiome could eventually become a new approach for treating severe food allergies. For now, researchers describe the results as an important early step toward understanding how gut microorganisms and the immune system may work together to influence allergic reactions.
Researchers focused on microorganisms found in the intestines of people who do not suffer from serious food allergies. Scientists have increasingly studied the relationship between gut bacteria and the immune system, as microorganisms in the digestive tract can influence how the body's immune system responds to substances entering the body.
In the study, patients with severe peanut allergies received treatment involving microorganisms obtained from healthy donors. According to the findings, six participants subsequently showed an increased ability to tolerate peanuts.
The result is significant because people with severe food allergies currently have limited treatment options, and accidental exposure to an allergen can cause a potentially life-threatening reaction.
The researchers believe that the effect may involve changes in the way beneficial gut bacteria influence bile-acid metabolism. These biological changes could affect immune responses and potentially make the immune system less likely to react excessively to food proteins.
The study adds to growing scientific evidence that food allergies may involve more than an abnormal immune response alone. Changes or imbalances in the gut microbiome could also play a role in determining how the immune system reacts to certain foods.
However, researchers have stressed that the findings do not yet represent a cure for peanut allergy. The study involved a limited number of participants, and larger clinical trials will be required to establish the treatment's effectiveness, safety and long-term benefits.
Scientists are also exploring ways to develop more controlled microbiome-based treatments. Instead of transferring complex communities of microorganisms, future therapies could potentially use carefully selected beneficial bacteria or their biological products.
If future clinical trials confirm the findings, manipulating the gut microbiome could eventually become a new approach for treating severe food allergies. For now, researchers describe the results as an important early step toward understanding how gut microorganisms and the immune system may work together to influence allergic reactions.